Glennon Michael J 4
Research Summary
AI-generated summary
PAVmed Director Michael J. Glennon Receives Award
What Happened
Michael J. Glennon, a director of PAVmed Inc. (PAVM), was granted 13,930 restricted shares on 2026-04-02. The shares were issued at $0.00 (award/grant), so the reported acquisition value is $0. This was an equity award (compensation), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-02; Form 4 filed: 2026-04-03 (timely filing).
- Shares granted: 13,930 restricted common shares; acquisition price: $0.00; reported value: $0.
- Vesting: Single vesting date of May 20, 2029 per issuer’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. Shares are subject to forfeiture if requisite service period is not completed. (Footnote as filed.)
- Shares owned following the transaction: not specified in the provided filing details.
Context
Restricted stock awards are a form of compensation that typically vest over time and may be forfeited if the executive or director leaves before the vesting date. Such grants are routine for aligning management/director incentives with shareholders and do not, by themselves, indicate a buy or sell signal in the market.